intestin
epitheli
cell
iec
constantli
expos
commens
flora
pathogen
challeng
iec
regul
innat
immun
respons
maintain
gut
homeostasi
remain
unclear
interferon
ifn
cytokin
produc
infect
type
ifn
receptor
ubiquit
express
type
iii
ifn
receptor
express
epitheli
cell
epithelium
specif
strongli
suggest
exclus
function
epitheli
surfac
rel
role
type
iii
ifn
establish
antivir
innat
immun
respons
human
iec
clearli
defin
use
minigut
organoid
defin
function
type
iii
ifn
protect
human
gut
viral
infect
show
primari
nontransform
human
iec
upon
viral
challeng
upregul
express
type
type
iii
ifn
transcript
level
secret
type
iii
ifn
supernat
howev
human
iec
respond
type
type
iii
ifn
produc
ifnstimul
gene
turn
induc
antivir
state
use
genet
ablat
either
type
type
iii
ifn
receptor
show
either
ifn
independ
restrict
viru
infect
human
iec
importantli
report
first
time
differ
mechan
ifn
establish
antivir
state
contrari
type
ifn
antivir
activ
induc
type
iii
ifn
strongli
depend
mitogenactiv
protein
kinas
signal
pathway
suggest
pathway
use
type
iii
ifn
nonredundantli
contribut
antivir
state
conclus
demonstr
human
intestin
epitheli
cell
specif
regul
innat
immun
respons
favor
type
iii
ifnmedi
signal
allow
effici
protect
pathogen
without
produc
excess
inflamm
result
strongli
suggest
type
iii
ifn
constitut
frontlin
antivir
respons
human
gut
propos
mucos
surfac
particularli
gastrointestin
tract
evolv
favor
type
iii
ifnmedi
respons
pathogen
infect
allow
spatial
segreg
signal
moder
product
inflammatori
signal
propos
key
maintain
gut
homeostasi
intestin
epitheli
cell
iec
constantli
expos
commens
flora
pathogen
challeng
iec
regul
innat
immun
respons
maintain
gut
homeostasi
remain
unclear
interferon
ifn
cytokin
produc
infect
type
ifn
receptor
ubiquit
express
type
iii
ifn
receptor
express
epitheli
cell
epithelium
specif
strongli
suggest
exclus
function
epitheli
surfac
rel
role
type
iii
ifn
establish
antivir
innat
immun
respons
human
iec
clearli
defin
use
minigut
organoid
defin
function
type
iii
ifn
protect
human
gut
viral
infect
show
primari
nontransform
human
iec
upon
viral
challeng
upregul
express
type
type
iii
ifn
transcript
level
secret
type
iii
ifn
supernat
howev
human
iec
respond
type
type
iii
ifn
produc
ifnstimul
gene
turn
induc
antivir
state
use
genet
ablat
either
type
type
iii
ifn
receptor
show
either
ifn
independ
restrict
viru
infect
human
iec
importantli
report
first
time
differ
mechan
ifn
establish
antivir
state
contrari
type
ifn
antivir
activ
induc
type
iii
ifn
strongli
depend
mitogenactiv
protein
kinas
signal
pathway
suggest
pathway
use
type
iii
ifn
nonredundantli
contribut
antivir
state
conclus
demonstr
human
intestin
epitheli
cell
specif
regul
innat
immun
respons
favor
type
iii
ifnmedi
signal
allow
effici
protect
pathogen
without
produc
excess
inflamm
result
strongli
suggest
type
iii
ifn
constitut
frontlin
antivir
respons
human
gut
propos
mucos
surfac
particularli
gastrointestin
tract
evolv
favor
type
iii
ifnmedi
respons
pathogen
infect
allow
spatial
segreg
signal
moder
product
inflammatori
signal
propos
key
maintain
gut
homeostasi
keyword
interferonlambda
intestin
epitheli
cell
mitogenactiv
protein
kinas
human
gut
microbiota
antivir
immun
mucos
immun
ifnmedi
antivir
protect
human
gut
frontier
immunolog
wwwfrontiersinorg
april
volum
articl
introduct
intestin
epitheli
cell
iec
line
surfac
intestin
assembl
continu
monolay
tightli
juxtapos
cell
primari
function
permit
nutrient
absorpt
balanc
electrolyt
water
level
also
act
barrier
separ
interior
exterior
milieu
enter
pathogen
face
establish
product
infect
lumen
intestin
constant
contact
everpres
microbiota
variou
proinflammatori
associ
product
eg
lp
surprisingli
microbi
load
elicit
constant
inflamm
intestin
physiolog
condit
sever
mechan
report
particip
toler
commens
flora
evid
suggest
iec
gener
innat
immun
respons
gut
specif
uniqu
tailor
perfect
respons
balanc
flare
control
pathogen
lumen
gut
without
caus
excess
local
inflamm
interferon
ifn
class
cytokin
often
produc
secret
upon
infect
particular
virus
ifn
bind
infect
uninfect
bystand
cell
induc
jak
statdepend
signal
cascad
lead
product
ifnstimul
gene
isg
isg
alert
cell
presenc
pathogen
confer
antivir
state
three
class
ifn
type
ii
iii
type
ii
ifn
mostli
specif
immun
cell
type
iii
ifn
express
immun
cell
epithelium
cell
make
relev
viral
infect
epithelium
surfac
type
ifn
compos
human
type
ifn
bind
interferon
alpha
receptor
ifnar
complex
compos
heterodim
four
subtyp
type
iii
ifn
also
call
type
iii
ifn
bind
heterodimer
receptor
complex
compos
interferonlambda
receptor
receptor
beta
type
iii
ifn
well
express
cell
contrast
type
iii
ifnspecif
receptor
express
mainli
epitheli
cell
ie
respiratori
tract
intestin
tract
hepatocyt
function
type
iii
ifn
intens
studi
murin
system
howev
date
report
describ
whether
two
ifn
act
differ
human
organ
current
view
type
iii
ifn
redund
induc
similar
signal
pathway
lead
express
compar
set
isg
model
support
work
lower
respiratori
tract
influenza
viru
iav
infect
multipl
line
evid
suggest
type
iii
ifn
particip
protect
iav
contrari
studi
focus
mous
gastrointestin
tract
shown
agerestrict
depend
ifn
neonat
mice
epithelium
cell
respond
type
iii
ifn
adult
mice
insensit
type
ifn
adult
anim
type
iii
ifn
control
local
viral
infect
epitheli
layer
type
ifn
control
system
viral
spread
similarli
human
hepatocyt
becom
refract
type
ifn
treatment
never
lose
abil
respond
type
iii
ifn
exampl
differenti
regul
type
type
iii
ifn
signal
epithelium
specif
type
iii
ifnmedi
immun
strongli
suggest
major
function
regulatori
differ
ifn
mucos
surfac
use
human
minigut
organoid
human
iec
line
studi
rel
role
type
type
iii
ifn
protect
human
gut
viral
infect
show
primari
nontransform
human
iec
respond
type
type
iii
ifn
produc
isg
use
genet
ablat
either
type
type
iii
ifn
receptor
show
either
ifn
independ
restrict
viru
infect
human
iec
howev
contrari
type
ifn
antivir
activ
induc
type
iii
ifn
strongli
depend
mitogenactiv
protein
kinas
mapk
signal
pathway
suggest
pathway
use
type
iii
ifn
nonredundantli
contribut
antivir
state
role
type
iii
ifn
mucos
surfac
epitheli
cell
extens
studi
mice
whether
two
ifn
type
antivir
activ
human
epitheli
cell
remain
much
less
character
particularli
human
intestin
epitheli
cell
hiec
investig
function
ifn
type
context
primari
untransform
human
cell
use
human
colon
intestin
minigut
organoid
ex
vivo
human
model
gut
fulli
reproduc
structur
architectur
human
intestin
tract
contain
major
intestin
cell
lineag
minigut
organoid
form
isol
intestin
crypt
contain
stem
cell
human
gut
colon
small
intestin
resect
multipl
donor
singl
crypt
grown
matrigel
h
postisol
open
crypt
start
reseal
evid
format
lumen
within
organoid
day
cultur
day
organoid
significantli
increas
size
figur
differenti
human
colon
organoid
display
typic
organ
clear
develop
lumen
local
ecadherin
basolater
side
cell
tight
junction
locat
apic
side
well
presenc
mucinsecret
goblet
cell
enteroendocrin
cell
syn
figur
address
whether
type
andor
type
iii
ifn
protect
human
gut
viral
infect
use
mammalian
reoviru
mrv
mrv
wellknown
viru
model
induc
immun
respons
infect
cell
sensit
type
iii
ifn
follow
use
term
type
type
iii
ifn
describ
ifn
ifn
respect
colon
organoid
infect
mrv
multipl
infect
moi
harvest
h
postinfect
hpi
viral
replic
assess
immunostain
reoviru
nonstructur
protein
quantif
viral
replic
use
quantit
realtim
qrt
pcr
shown
figur
mrv
effici
infect
human
minigut
organoid
evidenc
presenc
mrvinfect
cell
figur
left
panel
potent
replic
cours
infect
figur
right
panel
note
mrv
infect
sever
disrupt
structur
integr
human
minigut
organoid
figur
also
confirm
later
figur
mostli
fragment
piec
cellular
monolay
compar
intact
structur
observ
mockinfect
organoid
character
innat
immun
respons
gener
organoid
monitor
upregul
type
iii
ifn
two
repres
isg
viperin
cours
mrv
infect
found
viral
infect
organoid
induc
transcript
upregul
type
iii
ifn
lesser
extent
type
ifn
figur
congruent
detect
type
iii
ifn
supernat
infect
organoid
figur
addit
viral
infect
organoid
associ
upregul
isg
transcript
upregul
two
repres
isg
viperin
cours
mrv
infect
shown
figur
found
viral
infect
organoid
induc
upregul
type
iii
ifn
address
whether
ifn
turn
induc
express
isg
minigut
organoid
stimul
broad
rang
ifn
concentr
result
reveal
type
iii
ifn
induc
upregul
isg
dosedepend
manner
figur
interestingli
type
ifn
appear
potent
induc
higher
express
viperin
isg
compar
type
iii
ifn
figur
similar
result
found
multipl
isg
data
shown
also
observ
continu
increas
isg
mrna
level
concentr
type
ifn
increas
wherea
isg
transcript
level
quickli
reach
plateau
type
iii
ifntreat
cell
evalu
whether
type
andor
iii
ifn
protect
primari
human
iec
viral
infect
organoid
cultur
treat
viral
antigen
level
within
organoid
figur
complementarili
viral
replic
sever
impair
organoid
treat
either
ifn
assay
qrtpcr
figur
ensur
find
neither
donor
colon
specif
colon
organoid
differ
donor
colon
organoid
deriv
ileum
jejunum
similarli
pretreat
type
iii
ifn
infect
mrv
reduc
viral
infect
character
lower
express
level
mrv
protein
decreas
mrv
replic
observ
colon
organoid
gener
differ
donor
figur
supplementari
materi
ileum
figur
supplementari
materi
jejunum
figur
supplementari
materi
deriv
organoid
similar
result
found
use
vesicular
stomati
viru
vsv
unrel
model
viru
whose
replic
also
sensit
type
iii
ifn
pretreat
human
organoid
either
ifn
result
signific
inhibit
vsv
replic
measur
signific
decreas
bioluminesc
use
vsvexpress
luciferas
vsvluc
report
viral
replic
figur
supplementari
materi
togeth
result
demonstr
antivir
protect
role
type
iii
ifn
colon
ileum
jejunum
deriv
hiec
human
minigut
organoid
difficult
modifi
genet
therefor
order
better
character
function
mechan
type
iii
ifn
confer
hiec
antivir
state
use
human
colon
carcinomaderiv
cell
line
cell
infect
mrv
harvest
differ
time
point
postinfect
evalu
transcript
upregul
type
iii
ifn
viral
infect
cell
induc
upregul
type
type
iii
ifn
figur
similar
human
minigut
organoid
figur
viral
infect
induc
higher
transcript
upregul
type
iii
ifn
compar
type
ifn
figur
figur
supplementari
materi
address
whether
ifn
made
protein
level
secret
infect
cell
measur
amount
ifn
supernat
infect
cell
use
elisa
observ
viral
infect
minigut
organoid
figur
type
iii
ifn
found
supernat
figur
howev
type
ifn
detect
supernat
ad
exogen
inhibit
viral
infect
data
shown
address
whether
iec
respond
either
type
iii
ifn
treat
iec
type
iii
ifn
measur
express
level
isg
differ
time
point
postifn
treatment
like
human
minigut
organoid
figur
found
type
ifn
induc
higher
express
isg
viperin
compar
type
iii
ifn
figur
supplementari
materi
transcriptom
analysi
cell
treat
either
type
iii
ifn
reveal
type
ifn
consist
induc
determin
antivir
potenc
type
iii
ifn
cell
pretreat
cell
increas
concentr
ifn
prior
infect
mrv
de
novo
product
viral
protein
monitor
blot
mrv
nonstructur
protein
figur
show
type
iii
ifn
inhibit
viral
infect
dosedepend
manner
addit
cell
fix
hpi
fraction
cell
determin
immunofluoresc
demonstr
either
type
iii
ifn
decreas
number
mrvinfect
cell
level
viral
antigen
per
cell
figur
confirm
observ
virusspecif
cell
treat
increas
concentr
either
type
iii
ifn
subsequ
infect
vsvluc
report
viral
replic
measur
viral
infect
bioluminesc
show
similar
mrv
either
type
iii
ifn
capabl
inhibit
vsv
infect
hiec
dosedepend
manner
figur
togeth
result
show
either
type
iii
ifn
confer
cell
line
antivir
state
cell
phenocopi
antivir
respons
gener
primari
hiec
context
minigut
organoid
evalu
whether
delet
ifnar
ifnlr
render
human
iec
suscept
viral
infect
cell
lack
function
receptor
type
iii
ifn
infect
either
mrv
vsv
compar
wildtyp
scrambl
guid
rnaexpos
cell
immunofluoresc
analysi
reveal
loss
ifnar
slightli
increas
number
mrvinfect
cell
compar
control
cell
figur
affect
averag
fluoresc
intens
mrv
antigen
per
infect
cell
figur
interestingli
cell
appear
suscept
vsv
infect
number
vsvinfect
cell
amount
viral
antigen
cell
significantli
increas
cell
compar
control
cell
figur
f
confirm
protect
role
type
iii
ifn
viral
infect
human
iec
cell
pretreat
either
type
iii
ifn
subsequ
infect
mrv
vsv
type
iii
ifn
could
effici
inhibit
infect
mrv
vsv
control
cell
figur
h
expect
protect
effect
type
ifn
mrv
figur
left
panel
vsv
figur
longer
observ
cell
preserv
cell
convers
disrupt
specif
abolish
protect
effect
type
iii
ifn
type
ifn
similar
result
obtain
sever
ko
clone
figur
supplementari
materi
togeth
data
demonstr
human
cell
either
type
iii
ifn
capabl
independ
mediat
antivir
protect
map
kinas
requir
type
iii
type
ifn
antivir
activ
hiec
type
iii
ifn
signal
antivir
activ
depend
jakstat
pathway
inhibit
phosphoryl
block
product
isg
inhibit
ifnmedi
antivir
protect
sever
mapk
also
report
activ
contribut
isg
upregul
type
iii
ifnstimul
cell
role
mapk
pathway
antivir
function
type
iii
ifn
remain
unclear
found
type
iii
ifn
treatment
induc
phosphoryl
similar
kinet
cell
data
shown
type
iii
ifn
treatment
induc
phosphoryl
data
shown
next
address
whether
type
iii
ifn
activ
mapk
found
ifn
induc
phosphoryl
mapk
erk
jnk
extent
similar
kinet
figur
supplementari
materi
determin
role
stat
mapk
pathway
antivir
activ
ifn
use
specif
pharmacolog
inhibitor
combin
ifn
treatment
specif
inhibitor
toxic
test
cell
western
blot
analysi
figur
c
cell
pretreat
indic
concentr
type
iii
ifn
h
prior
infect
vesicular
stomati
viru
vsv
express
firefli
luciferas
vsv
express
luciferas
moi
viral
replic
assay
measur
luciferas
activ
sampl
luciferas
activ
measur
triplic
express
percentag
activ
present
vsvinfect
cell
without
ifn
treatment
set
mean
valu
obtain
three
independ
experi
plot
error
bar
indic
sd
p
p
unpair
ttest
figur
specif
inhibit
seen
across
rang
concentr
figur
note
partial
inhibit
antivir
activ
type
ifn
observ
high
concentr
jnk
inhibitor
figur
concentr
cell
viabil
sever
affect
figur
supplementari
materi
type
iii
ifn
restrict
depend
mapk
independ
ifn
concentr
figur
supplementari
materi
valid
nondepend
type
ifn
mapk
result
differ
ifn
concentr
use
stimul
cell
altogeth
result
demonstr
fundament
role
statdepend
signal
confer
type
type
iii
ifn
antivir
activ
addit
demonstr
uniqu
role
mapk
toward
induc
antivir
state
induc
type
iii
ifn
type
ifn
although
shown
multipl
cell
line
ifn
induc
activ
mapk
import
kinas
ifnmedi
antivir
state
never
report
knowledg
suggest
depend
mapk
might
cell
type
specif
ensur
antivir
activ
type
iii
ifn
primari
nontransform
hiec
depend
mapk
use
minigut
organoid
cultur
system
colon
organoid
treat
pharmacolog
inhibitor
jakstat
mapk
signal
pathway
follow
pretreat
type
type
iii
ifn
organoid
infect
vsv
eight
hpi
organoid
harvest
impact
pharmacolog
inhibitor
antivir
activ
ifn
measur
expect
inhibit
jakstat
signal
pathway
fulli
restor
vsv
infect
level
similar
infect
organoid
absenc
ifn
figur
confirm
jakstat
signal
pathway
key
type
type
iii
ifn
activ
primari
hiec
interestingli
similar
cell
inhibit
either
jnk
mapk
partial
impair
antivir
activ
type
iii
ifn
human
minigut
organoid
figur
signific
effect
mapk
inhibit
supplementari
materi
strongli
impair
antivir
activ
either
type
iii
ifn
vsv
mrv
figur
interestingli
inhibit
mapk
specif
inhibitor
effect
phosphoryl
kinet
figur
supplementari
materi
strongli
affect
antivir
protect
confer
type
iii
ifn
except
cell
line
infect
vsv
express
luciferas
vsvluc
moi
viral
replic
assay
measur
luciferas
activ
cell
line
luciferas
activ
measur
triplic
express
rel
scrambl
control
cell
set
g
c
except
cell
line
treat
type
ifn
ruml
equival
ngml
type
iii
ifn
ngml
indic
time
point
prior
infect
mrv
h
f
except
cell
line
treat
type
ifn
ruml
equival
ngml
type
iii
ifn
ngml
h
prior
infect
vsvluc
data
bh
repres
mean
valu
three
independ
experi
error
bar
indic
sd
p
p
ns
signific
unpair
ttest
type
ifnmedi
antivir
activ
observ
effect
inhibit
erkdepend
signal
antivir
activ
ifn
determin
nd
sinc
treatment
minigut
organoid
erk
inhibitor
induc
disrupt
death
organoid
cultur
figur
data
shown
altogeth
result
confirm
mapk
signal
pathway
particip
establish
antivir
state
mediat
type
iii
ifn
primari
nontransform
hiec
recent
year
larg
interest
uncov
specif
role
type
iii
ifn
epitheli
cell
includ
lung
epithelium
gastrointestin
tract
epithelium
hepatocyt
work
exploit
human
minigut
organoid
perform
function
character
type
iii
ifn
human
primari
intestin
cell
context
found
upon
viral
infect
human
iec
strongli
upregul
type
iii
ifn
transcript
level
although
type
iii
ifn
found
secret
iec
demonstr
either
type
iii
ifn
induc
product
isg
product
associ
establish
antivir
state
effici
protect
iec
viral
infect
importantli
reveal
type
iii
ifnmedi
signal
allow
effici
protect
viral
infect
limit
isg
product
human
colon
organoid
mock
incub
black
bar
preincub
pyridon
panjak
inhibitor
erk
inhibitor
inhibitor
jnk
inhibitor
one
hour
posttreat
organoid
mock
treat
black
bar
cotreat
type
ifn
ruml
equival
ngml
type
iii
ifn
ngml
h
organoid
infect
vsv
express
luciferas
multipl
infect
eight
hpi
viral
replic
assay
measur
luciferas
activ
data
normal
nonifntr
sampl
inhibitor
set
mean
valu
obtain
three
independ
experi
plot
error
bar
indic
sd
p
p
ns
signific
unpair
ttest
nd
determin
propos
repres
mechan
limit
inflamm
gut
remain
respons
pathogen
addit
genet
ablat
ifn
signal
use
crispr
ko
ifn
receptor
demonstr
type
iii
ifn
independ
mediat
antivir
activ
compar
analys
reveal
ifn
induc
set
isg
antivir
state
depend
jakstat
signal
pathway
importantli
discov
type
iii
ifnmedi
type
ifnmedi
antivir
activ
depend
mapk
signal
pathway
work
establish
type
iii
ifn
provid
potent
antivir
protect
human
gut
identifi
first
time
fundament
differ
mechan
two
ifn
type
establish
antivir
state
primari
hiec
sinc
implement
organoid
cultur
system
gain
substanti
increas
interest
field
cellular
biolog
medicin
recent
organoid
also
use
studi
describ
infecti
diseas
present
studi
exploit
organoid
describ
respons
hiec
upon
pathogen
challeng
also
perform
function
character
type
iii
ifn
context
primari
nontransform
hiec
contrast
data
murin
iec
result
demonstr
hiec
mount
antivir
state
respons
either
type
iii
ifn
treatment
similar
observ
made
lung
epithelium
type
type
iii
ifn
particip
protect
iav
function
character
perform
minigut
organoid
colon
carcinomaderiv
cell
line
reveal
although
cell
transcript
upregul
type
iii
ifn
secret
littl
type
ifn
favor
type
iii
ifn
respons
type
ifn
observ
epitheli
cell
stimul
variou
virus
pathogenassoci
molecular
pattern
shown
although
ifn
protect
airway
epitheli
cell
viral
infect
type
iii
ifn
preferenti
made
respons
influenza
infect
similarli
shown
upon
stimul
iec
doubl
strand
rna
structur
analog
polyinosin
cytidyl
acid
poli
c
type
iii
ifn
secret
cell
although
type
iii
ifn
upregul
transcript
level
addit
report
human
hepatocyt
becom
refract
type
ifn
maintain
respons
type
iii
ifn
consequ
favor
type
iii
ifn
signal
appear
common
strategi
develop
epitheli
surfac
airway
hepatocyt
intestin
tract
mount
antivir
respons
remain
unclear
whether
translat
secret
type
ifn
restrict
hiec
date
littl
known
mechan
lead
type
iii
ifn
secret
shown
signal
downstream
mitochondrialassoci
mav
mitochondri
antiviralsign
protein
induc
secret
type
ifn
inhibit
brefeldin
contrari
antivir
activ
gener
follow
activ
peroxisomalassoci
mav
insensit
brefeldin
later
demonstr
briefeldinainsensit
antivir
state
mediat
type
iii
ifn
secret
follow
activ
peroxisom
mav
observ
strongli
suggest
type
iii
ifn
secret
cell
two
distinct
mechan
although
type
iii
ifn
stimul
hiec
result
significantli
less
induct
isg
compar
type
ifn
figur
figur
supplementari
materi
found
type
iii
ifn
slightli
less
potent
protect
cell
viral
infect
figur
lower
induct
isg
cell
type
specif
recent
public
address
role
ifn
hepatocyt
also
report
type
iii
ifn
induc
less
isg
compar
type
ifn
howev
studi
antivir
potenc
ifn
address
sidebysid
type
iii
ifn
could
consid
milder
ifn
favor
epitheli
surfac
least
intestin
epithelium
due
abil
confer
antivir
state
without
induc
excess
amount
isg
might
result
induct
local
proinflammatori
signal
molecular
mechan
type
iii
ifn
signal
modul
isg
express
remain
unknown
desensit
possibl
mechan
ifn
signal
reduc
follow
stimul
differ
neg
regul
ifn
signal
might
use
regul
turn
isg
express
signal
transduct
strongli
depend
amount
receptor
affin
ligand
receptor
known
type
ifn
strong
affin
receptor
differ
affin
type
iii
ifn
respect
receptor
differ
amount
type
iii
ifn
receptor
surfac
hiec
might
partial
respons
observ
differ
magnitud
isg
express
function
character
type
iii
ifn
comparison
type
ifn
suggest
cytokin
function
redund
induc
set
isg
howev
restrict
type
iii
ifn
receptor
epithelium
cell
suggest
type
iii
ifn
might
uniqu
function
provid
specif
advantag
epitheli
surfac
sever
studi
tri
character
function
differ
human
hepatocyt
murin
model
system
lung
intestin
tract
date
main
differ
ifn
explain
spatial
restrict
type
iii
ifn
receptor
epitheli
surfac
work
demonstr
type
iii
ifn
induc
less
isg
compar
type
ifn
importantli
unravel
first
time
fundament
differ
mechan
ifn
mount
antivir
state
hiec
demonstr
antivir
activ
type
iii
ifn
partial
depend
mapk
case
type
ifn
interestingli
inhibit
mapk
influenc
express
viperin
isg
data
shown
remain
import
task
futur
work
dissect
signal
downstream
mapk
particip
antivir
activ
type
iii
ifn
ifn
report
activ
mapk
interest
address
whether
depend
type
iii
ifn
mapk
epithelium
cell
specif
intestin
epithelium
cell
specif
known
whether
hiec
protect
viral
infect
secret
respond
ifn
propos
rotaviru
infect
ifn
produc
immun
cell
epitheli
cell
inde
rotaviru
infect
hiec
multipl
strategi
develop
viru
inhibit
innat
immun
respons
particularli
inhibit
type
iii
ifn
product
addit
block
ifn
signal
hiec
lead
increas
rotaviru
replic
data
clearli
show
first
time
primari
hiec
infect
virus
block
ifn
synthesi
hiec
produc
secret
least
type
iii
ifn
mayb
type
ifn
detect
limit
elisa
assay
order
protect
complementarili
ko
ifnlr
render
hiec
suscept
viral
infect
figur
consid
result
type
iii
ifn
secret
hiec
tempt
propos
iec
evolv
favor
type
iii
ifn
type
ifn
allow
similar
protect
pathogen
limit
product
isg
perspect
epithelium
alway
expos
extracellular
environ
commens
challeng
might
repres
smart
strategi
regul
immun
respons
order
achiev
balanc
respons
pathogen
versu
toler
commens
restrict
signal
type
iii
ifn
allow
respons
compartment
type
iii
ifn
signal
limit
mostli
epitheli
cell
therebi
limit
systemat
inflamm
find
epithelium
cell
gastrointestin
tract
specul
first
respons
pathogen
threat
gener
hiec
respons
character
type
iii
ifnmedi
signal
therefor
limit
isg
proinflammatori
cytokin
product
first
wave
respons
type
iii
ifn
produc
iec
alon
might
enough
clear
enter
viru
infect
second
wave
respons
might
gener
recruit
immun
cell
site
epithelium
infect
turn
produc
variou
cytokin
includ
type
ifn
ifn
mediat
strong
induct
isg
proinflammatori
signal
power
combat
pathogen
infect
mucosa
also
provid
system
protect
uniqu
tailor
respons
would
fundament
mainten
human
gut
homeostasi
human
colon
carcinoma
cell
atcc
maintain
mixtur
dulbecco
modifi
eagl
medium
gibco
supplement
fetal
bovin
serum
penicillinstreptomycin
gibco
reoviru
mrv
strain
type
clone
deriv
stock
origin
obtain
bernard
n
field
grown
purifi
standard
protocol
vsvluc
kind
gift
sean
whelan
harvard
medic
school
produc
describ
ref
moi
use
infect
cell
organoid
titer
determin
describ
ref
cell
mrv
infect
mrv
purifi
csclgradient
stock
titr
fluoresc
foci
form
assay
express
ffu
cell
titer
calcul
determin
tissu
cultur
infect
dose
express
ffuml
cell
infect
describ
ref
moi
determin
ratio
infect
cell
determin
fluoresc
foci
form
assay
total
number
cell
moi
use
base
experi
result
infect
determin
fluoresc
assay
minigut
organoid
mrv
infect
organoid
remov
matrigel
ad
coldpb
min
liquefi
matrigel
organoid
separ
centrifug
g
min
total
number
cell
per
organoid
sampl
measur
use
haematocytomet
organoid
resuspend
cultur
medium
contain
mrv
use
moi
determin
cell
infect
minigut
organoid
infect
cell
detect
per
organoid
discrep
organoid
infect
might
due
natur
organoid
residu
matrigel
might
absorb
neutral
mrv
mrv
stock
titr
directli
organoid
serial
dilut
infect
subsequ
immunostain
moi
calcul
ratio
number
infectedtot
number
cellsorganoid
moi
use
infect
organoid
human
colon
tissu
receiv
colon
resect
univers
hospit
heidelberg
approv
studi
protocol
human
ileum
jejunum
purchas
baylor
univers
transfer
sign
mta
stem
cell
contain
crypt
isol
follow
mm
edta
dissoci
tissu
sampl
h
crypt
spun
wash
icecold
pb
fraction
enrich
crypt
resuspend
matrigel
maintain
basal
cultur
media
advanc
supplement
penicillin
streptomycin
mm
hepe
vv
condit
media
life
technolog
life
technolog
mm
glutamax
gibco
ngml
egf
invitrogen
spondin
peprotech
ngml
noggin
peprotech
nm
gastrin
sigma
mm
nacetylcystein
sigma
mm
nicotinamid
sigma
nm
tocri
differenti
media
except
without
nicotinamid
reduc
level
rspondin
noggin
organoid
stain
cryosect
embed
organoid
tissuetek
rabbit
polyclon
antibodi
reoviru
use
dilut
immunostain
western
blot
commerci
avail
primari
antibodi
goat
polyclon
antibodi
recogn
santa
cruz
biotechnolog
rabbit
polyclon
santa
graz
biotechnolog
mous
monoclon
antibodi
recogn
bd
transduct
respect
invitrogen
ecadherin
bd
transduct
rabbit
polyclon
antiphospho
antiphosphosapkjnk
antisapkjnk
antiphospho
antibodi
obtain
cell
signal
secondari
antibodi
conjug
molecular
probe
horseradish
peroxidas
hrp
sigmaaldrich
direct
anim
sourc
antimous
ge
healthcar
antirabbit
ge
healthcar
antigoat
jackson
immunoresearch
antibodi
coupl
hrp
use
secondari
antibodi
western
blot
dilut
human
recombin
obtain
biomol
recombin
human
purchas
peprotech
pharmacolog
inhibitor
use
pyridon
calbiochem
tocri
bioscienc
tocri
bioscienc
jnk
cell
signal
rna
isol
cdna
qpcr
rna
harvest
cell
use
nucleospin
rna
extract
kit
macherynagel
follow
manufactur
instruct
cdna
made
use
iscript
revers
transcriptas
biorad
ng
total
rna
per
manufactur
instruct
qrtpcr
perform
use
ssoadvanc
sybr
green
biorad
per
manufactur
instruct
tbp
use
normal
gene
type
ifn
analyz
use
primer
specif
human
type
iii
ifn
analyz
use
primer
specif
human
express
level
fold
induct
investig
gene
calcul
normal
untreat
mock
sampl
normal
gene
time
harvest
media
remov
cell
rins
pb
lyse
ripa
mm
sodium
chlorid
triton
sodium
deoxychol
sodium
dodecyl
sulfat
sd
mm
tri
ph
phosphatas
proteas
inhibitor
sigmaaldrich
min
room
temperatur
rt
lysat
collect
equal
protein
amount
separ
sdspage
blot
onto
pvdf
membran
wetblot
biorad
membran
block
milk
bsa
tb
contain
tween
tbst
h
rt
primari
antibodi
dilut
block
buffer
incub
overnight
membran
wash
tbst
min
rt
secondari
antibodi
dilut
block
buffer
incub
rt
h
rock
membran
wash
tbst
min
rt
hrp
detect
reagent
ge
healthcar
mix
ad
membran
incub
rt
min
membran
expos
film
develop
indirect
immunofluoresc
assay
cell
seed
plate
cell
fix
paraformaldehyd
min
rt
wash
pb
permeabil
use
triton
min
block
bsa
pb
h
rt
cell
incub
primari
antibodi
bsa
h
rt
wash
pb
cell
stain
secondari
antibodi
bsa
min
rt
stain
minigut
organoid
cryosect
fix
ethanol
min
rt
follow
min
incub
icecold
aceton
block
goat
serum
pb
contain
triton
h
rt
section
incub
primari
antibodi
block
solut
h
rt
overnight
wash
pb
section
stain
secondari
antibodi
bsa
pb
contain
triton
h
rt
nuclear
dna
stain
prolong
gold
dapi
molecular
probe
slide
imag
epifluoresc
use
nikon
eclips
ti
nikon
microscop
confoc
tile
scan
zeiss
lsm
zeiss
microscop
imag
process
perform
use
fiji
softwar
infect
experi
percentag
infect
cell
determin
count
least
cell
detect
field
view
condit
vsv
luciferas
assay
cell
seed
white
bottom
plate
cell
pretreat
prior
infect
indic
increas
concentr
type
type
iii
ifn
vsvluc
moi
ad
well
infect
allow
proceed
h
end
infect
media
remov
cell
wash
pb
lyse
cell
lysi
buffer
promega
rt
min
dilut
steadi
glo
promega
pb
ad
cell
incub
rt
min
luminesc
read
use
omega
luminomet
total
rna
purifi
describ
cell
treat
ruml
type
ifn
ngml
type
iii
ifn
hr
microarray
data
process
use
softwar
packag
r
differenti
express
probe
set
determin
compar
triplic
stimul
sampl
three
unstimul
sampl
signific
defin
minimum
absolut
twofold
chang
express
qvalu
fals
discoveri
rate
elisa
contain
supernat
cell
quantifi
use
human
ifnbeta
elisa
kit
diy
ifnlr
elisa
kit
pblinterferon
sourc
per
manufactur
instruct
knockout
cell
achiev
use
system
three
differ
singleguid
rna
sgrna
per
gene
use
target
code
region
insert
lentivir
vector
lenticrispr
addgen
also
encod
nucleas
follow
sgrna
use
gcggctgcggacaacaccca
gaccctagtgctcgtcgccg
tgaggtggcattctg
gaagg
lentivirus
produc
cell
transduc
two
time
use
dilut
stock
lentivir
particl
encod
sgrna
shown
data
obtain
use
cell
clone
treat
sgrna
analog
result
obtain
cell
clone
gener
sgrna
establish
ko
cell
clonal
select
perform
via
singlecel
dilut
plate
ko
confirm
function
test
studi
carri
accord
recommend
univers
hospit
heidelberg
written
inform
consent
subject
subject
gave
written
inform
consent
accord
declar
helsinki
protocol
approv
ethic
commiss
univers
hospit
heidelberg
approv
studi
protocol
would
like
thank
dr
marco
binder
bruno
gali
axel
szabowski
dkfz
critic
read
comment
would
also
like
thank
tim
waterbo
assist
luminex
platform
supplementari
materi
articl
found
onlin
http
supplementarymateri
c
cell
treat
type
ifn
ruml
equival
ngml
type
iii
ifn
ngml
h
identif
ifninduc
isg
perform
transcript
profil
use
illumina
microarray
character
differ
ifnar
ifnlr
knockout
ko
cell
clone
gener
use
crisprca
system
ifnar
ifnlr
ko
clone
treat
type
interferon
ifn
ruml
equival
ngml
type
iii
ifn
ngml
h
ifn
signal
measur
immunoblot
use
load
control
repres
immunoblot
three
independ
experi
shown
b
except
ifn
signal
evalu
monitor
induct
ifnstimul
gene
rel
quantif
viperin
indic
time
postifn
treatment
use
qrtpcr
data
normal
tbp
express
rel
untreat
control
cell
time
point
repres
experi
three
independ
experi
shown
c
cell
line
treat
type
ifn
ruml
equival
ngml
type
iii
ifn
ngml
h
prior
infect
vsvexpress
luciferas
multipl
infect
viral
replic
assay
measur
luciferas
activ
result
express
rel
mockifntr
control
cell
gener
scrambl
control
grna
set
mean
valu
obtain
two
independ
experi
plot
error
bar
indic
sd
